<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To assess the frequency of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA1</z:e> (spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 1), SCA2, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> (spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 3/<z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e>), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA7</z:e>, and DRPLA (dentatorubropallidoluysian <z:mpath ids='MPATH_127'>atrophy</z:mpath>) CAG trinucleotide repeat expansions [(CAG)n] among persons diagnosed with hereditary SCA from Chinese families </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: Spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 1, SCA2, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA7</z:e>, and DRPLA (CAG)n mutation were detected with the polymerase chain reaction, highly denaturing <z:chebi fb="0" ids="53656">polyacrylamide</z:chebi> gel electrophoresis, and silver staining technique in 167 patients with <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> SCA from 85 Chinese families and 37 patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> SCA </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 1 (CAG)n mutation in 7 patients from 4 kindreds (4.70%) was expanded to 53 to 62 repeats </plain></SENT>
<SENT sid="3" pm="."><plain>Spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 2 (CAG)n mutation in 12 patients from 5 kindreds (5.88%) was expanded to 42 to 47 repeats </plain></SENT>
<SENT sid="4" pm="."><plain>Spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 3/<z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> (CAG)n mutation in 83 patients from 41 kindreds (48.23%) was expanded to 68 to 83 repeats </plain></SENT>
<SENT sid="5" pm="."><plain>Sixty-five patients from 35 kindreds (41.19%) and 37 patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> SCA did not test positive for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA1</z:e>, SCA2, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA6</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA7</z:e>, or DRPLA </plain></SENT>
<SENT sid="6" pm="."><plain>There was a predictable inverse relationship between the number of CAG repeats and the age at <z:hpo ids='HP_0003674'>onset</z:hpo> for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> and SCA2 </plain></SENT>
<SENT sid="7" pm="."><plain>Clinically, <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0001265'>hyporeflexia</z:hpo> were more frequent in patients with SCA2, while <z:hpo ids='HP_0007318'>spasticity, hyperreflexia</z:hpo>, and <z:hpo ids='HP_0003487'>Babinski signs</z:hpo> were more frequent in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>, and those might be helpful in clinical work to primarily distinguish patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> and SCA2 from others with different types of SCA </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The frequency of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> is substantially higher than that of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA1</z:e> and SCA2 in patients with <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> SCA from Chinese kindreds, who are non-Portuguese </plain></SENT>
<SENT sid="9" pm="."><plain>Clinical expressions of the various types of SCAs overlap one another; therefore, for clinical study it is important to make a gene diagnosis and genetic classification for patients with SCA </plain></SENT>
</text></document>